These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

395 related articles for article (PubMed ID: 38169011)

  • 1. Targeting the key players of phenotypic plasticity in cancer cells by phytochemicals.
    Fakhri S; Moradi SZ; Abbaszadeh F; Faraji F; Amirian R; Sinha D; McMahon EG; Bishayee A
    Cancer Metastasis Rev; 2024 Mar; 43(1):261-292. PubMed ID: 38169011
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Mapping Phenotypic Plasticity upon the Cancer Cell State Landscape Using Manifold Learning.
    Burkhardt DB; San Juan BP; Lock JG; Krishnaswamy S; Chaffer CL
    Cancer Discov; 2022 Aug; 12(8):1847-1859. PubMed ID: 35736000
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Anti-Cancer Potential of Phytochemicals: The Regulation of the Epithelial-Mesenchymal Transition.
    Liu S; Li L; Ren D
    Molecules; 2023 Jun; 28(13):. PubMed ID: 37446730
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Epithelial Mesenchymal Transition in Cancer Progression: Prev entive Phytochemicals.
    Illam SP; Narayanankutty A; Mathew SE; Valsalakumari R; Jacob RM; Raghavamenon AC
    Recent Pat Anticancer Drug Discov; 2017; 12(3):234-246. PubMed ID: 28440207
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Epithelial-to-mesenchymal transition in cancer progression: unraveling the immunosuppressive module driving therapy resistance.
    Singh D; Siddique HR
    Cancer Metastasis Rev; 2024 Mar; 43(1):155-173. PubMed ID: 37775641
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cancer cell plasticity: from cellular, molecular, and genetic mechanisms to tumor heterogeneity and drug resistance.
    Bhat GR; Sethi I; Sadida HQ; Rah B; Mir R; Algehainy N; Albalawi IA; Masoodi T; Subbaraj GK; Jamal F; Singh M; Kumar R; Macha MA; Uddin S; Akil ASA; Haris M; Bhat AA
    Cancer Metastasis Rev; 2024 Mar; 43(1):197-228. PubMed ID: 38329598
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Identifying inhibitors of epithelial-mesenchymal plasticity using a network topology-based approach.
    Hari K; Sabuwala B; Subramani BV; La Porta CAM; Zapperi S; Font-Clos F; Jolly MK
    NPJ Syst Biol Appl; 2020 May; 6(1):15. PubMed ID: 32424264
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Epithelial/mesenchymal plasticity: how have quantitative mathematical models helped improve our understanding?
    Jolly MK; Tripathi SC; Somarelli JA; Hanash SM; Levine H
    Mol Oncol; 2017 Jul; 11(7):739-754. PubMed ID: 28548388
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Dynamical hallmarks of cancer: Phenotypic switching in melanoma and epithelial-mesenchymal plasticity.
    Jain P; Pillai M; Duddu AS; Somarelli JA; Goyal Y; Jolly MK
    Semin Cancer Biol; 2023 Nov; 96():48-63. PubMed ID: 37788736
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Hybrid epithelial/mesenchymal phenotypes promote metastasis and therapy resistance across carcinomas.
    Jolly MK; Somarelli JA; Sheth M; Biddle A; Tripathi SC; Armstrong AJ; Hanash SM; Bapat SA; Rangarajan A; Levine H
    Pharmacol Ther; 2019 Feb; 194():161-184. PubMed ID: 30268772
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Phytochemicals in cancer cell chemosensitization: Current knowledge and future perspectives.
    Khatoon E; Banik K; Harsha C; Sailo BL; Thakur KK; Khwairakpam AD; Vikkurthi R; Devi TB; Gupta SC; Kunnumakkara AB
    Semin Cancer Biol; 2022 May; 80():306-339. PubMed ID: 32610149
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Phenotypic plasticity and epithelial-to-mesenchymal transition in the behaviour and therapeutic response of oral squamous cell carcinoma.
    Vig N; Mackenzie IC; Biddle A
    J Oral Pathol Med; 2015 Oct; 44(9):649-55. PubMed ID: 25594908
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cellular Plasticity in Cancer.
    Yuan S; Norgard RJ; Stanger BZ
    Cancer Discov; 2019 Jul; 9(7):837-851. PubMed ID: 30992279
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A mechanism for epithelial-mesenchymal heterogeneity in a population of cancer cells.
    Tripathi S; Chakraborty P; Levine H; Jolly MK
    PLoS Comput Biol; 2020 Feb; 16(2):e1007619. PubMed ID: 32040502
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cancer cells exhibit clonal diversity in phenotypic plasticity.
    Mathis RA; Sokol ES; Gupta PB
    Open Biol; 2017 Feb; 7(2):. PubMed ID: 28202626
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Phenotypic plasticity in prostate cancer: role of intrinsically disordered proteins.
    Mooney SM; Jolly MK; Levine H; Kulkarni P
    Asian J Androl; 2016; 18(5):704-10. PubMed ID: 27427552
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Therapeutic targeting approach on epithelial-mesenchymal plasticity to combat cancer metastasis.
    Mishra AB; Nishank SS
    Med Oncol; 2023 May; 40(7):190. PubMed ID: 37247000
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Tackling tumor heterogeneity and phenotypic plasticity in cancer precision medicine: our experience and a literature review.
    Sheng S; Margarida Bernardo M; Dzinic SH; Chen K; Heath EI; Sakr WA
    Cancer Metastasis Rev; 2018 Dec; 37(4):655-663. PubMed ID: 30484007
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Controlling metastatic cancer: the role of phytochemicals in cell signaling.
    Kapinova A; Kubatka P; Liskova A; Baranenko D; Kruzliak P; Matta M; Büsselberg D; Malicherova B; Zulli A; Kwon TK; Jezkova E; Blahutova D; Zubor P; Danko J
    J Cancer Res Clin Oncol; 2019 May; 145(5):1087-1109. PubMed ID: 30903319
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Update on Epithelial-Mesenchymal Plasticity in Cancer Progression.
    Fontana R; Mestre-Farrera A; Yang J
    Annu Rev Pathol; 2024 Jan; 19():133-156. PubMed ID: 37758242
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 20.